CombiMatrix Corporation Announces That Permission Has Been Granted to Begin Clinical Trial for Leuchemix, Inc. Drug

September 29, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MUKILTEO, Wash., Sept. 29, 2008 (GLOBE NEWSWIRE) -- Leuchemix Corporation announced that permission to undertake clinical safety trials of its drug LC-1, for leukemia, has been granted and that the sponsored trial will begin shortly.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Phase 1